Celldex Therapeutics buy Cantor Fitzgerald
Start price
22.03.24
/
50%
€38.80
Target price
22.03.25
€61.99
Performance (%)
-1.55%
Price
02.05.24
€38.20
Summary
This prediction is currently active. With a performance of -1.55%, the BUY prediction for Celldex Therapeutics by Cantor_Fitzgerald is down slightly. This prediction currently runs until 22.03.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Celldex Therapeutics | 12.353% | 12.353% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $67.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.80
03.11.23
03.11.23
€48.43
03.11.24
03.11.24
60.50%
02.05.24
02.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.00
12.10.23
12.10.23
€51.15
12.10.24
12.10.24
44.80%
02.05.24
02.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.80
27.09.23
27.09.23
€51.25
27.09.24
27.09.24
40.31%
02.05.24
02.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.80
16.08.23
16.08.23
€49.46
16.08.24
16.08.24
37.41%
02.05.24
02.05.24